XpressBioX
Holdings
own 2025 accountsThis companyXpressBioX1 holding, 1 country
2025 accounts
Belgium 1 Equity Result
- BE -€9.5m result -€6.5m
Source: list of holdings in its own 2025 accounts. Every holding stands with its own latest accounts.
Parent
France · 100% of the shares
At the same address
Avenue du Parc Industriel 89, 4041 Herstal · 3 other companies| Sartorius Xpress Biologics
registered office since 28-04-2014 · founded in 2014 · negative equity (2025) |
76 FTE (2025) 0550.686.915 |
| Sartorius Accessia Pharma
registered office since 22-03-2016 · founded in 2016 · negative equity (2025) |
4.8 FTE (2025) 0650.670.852 |
| OP2LYSIS DEVELOPMENT
establishment since 17-06-2021 · founded in 2021 |
1 FTE (2024) 0769.816.843 |
Holdings and subsidiaries
1 holding · 2 subsidiaries, including indirect onesHoldings 1
Share, source and own figures per holding (1)
- subsidiaryEquity -€9.5m Loss of €6.5m in 2025 (loss of €2.2m in 2024) Checked score100%
All subsidiaries, including indirect ones 2
XpressBioX or one of its subsidiaries holds more than half of the shares of these companies. A company it consolidates per the LEI register is listed too.
100%1 subsidiary
- 100%
Holdings through the years 2021 to 2025
| Name | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100% | |||||
Source: list of holdings in its own accounts
Board mandates elsewhere
1 board mandateBoard mandates of XpressBioXXpressBioX sits on their board1
Director
Founded in 2014 · 76 FTE (2025) · negative equity
Connections & network
1 connected companyThe connected companies are in the list.
This company
Company
Director
Shareholding
+N: links not shown yet
Bankruptcy, dissolution or liquidation
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
via and · Director · deed of 25-04-2024
Founded in 2016 · 4.8 FTE (2025) · negative equity